Hap Trading, LLC Vaxart, Inc. Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.75 - $2.24 $5,775 - $17,248	-7,700 Reduced 16.74%	38,300 $0
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $21,527 - $46,350	10,300 Added 28.85%	46,000 $5,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $5.28 $52,380 - $102,432	-19,400 Reduced 35.21%	35,700 $15,000
Q1 2022 May 12, 2022	SELL	$4.29 - $6.64 $416,988 - $645,408	-97,200 Reduced 63.82%	55,100 $25,000
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $225,029 - $310,440	39,000 Added 34.42%	152,300 $62,000
Q3 2021 Nov 10, 2021	BUY	$6.67 - $9.8 $46,023 - $67,620	6,900 Added 6.48%	113,300 $105,000
Q2 2021 Aug 11, 2021	BUY	$5.06 - $10.78 $538,384 - $1.15 Million	106,400 New	106,400 $110,000
Q1 2021 May 14, 2021	SELL	$5.64 - $23.33 $642,396 - $2.66 Million	-113,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $398,650 - $908,922	113,900 New	113,900 $110,000

108

37.9M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $93.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.